Roman Braun

About Roman Braun

Diligent scientific leader with broad experience in gene & cell therapy, vaccine development, virology and quantitative research. Subject matter expert in immunology with a keen sense for business development, partner relationships, and networking in pharmaceutical and biotech sectors. Global experience working with peers and industry leaders from Asia, Africa, Europe, North America, and Latin America. Exceptional communication, interpersonal, and listening skills to translate complex concepts into workable ideas for technical and non-technical audiences. PROFILE• Efficient project manager with experience leading interdisciplinary research teams to generate a novel approach to livestock vaccine development, two high- impact publications, and a follow-up project in the European Horizon 2020 framework.• Strong analytical skills and the ability to work with a broad array of data sets to generate graphical and textual summarization for both expert and lay audiences presented in 3 oral presentations at international congresses and multiple events for audience of diverse background.• Multilingual communicator with fluency in 4 languages and experience in working with professionals from diverse backgrounds in Asia, Africa, Europe, North and Latin America, resulting in global network of industry professionals.Current location: Boston, MA

Experience

1. Director of Business Development

   Envisagenics

   Jun 2023 — Present

   Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. We focus on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered.Our breakthrough technology, SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence. We are using our software to identify splicing errors causative of diseases, identify the right drug-targets and develop RNA therapeutics through partnerships and collaborations with Biopharma. Our in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost, and failure risk of drug development programs.

Education

• University of Bern

  Master of Science (M.Sc.), Molecular Life Science

  2012 — 2013

• University of Bern

  PhD in Immunology, Microbiology and Immunology

  2013 — 2016

• University of Konstanz

  Bachelor of Science (B.Sc.), Biological Sciences

  2008 — 2011

Skills

• Spanish
• English
• German
• Swiss German
• Scuba Diving
• Microsoft Office
• Ios
• Windows
• Self Defense
• French
• Immunology
• Microbiology
• Biochemistry
• Intercultural Skills
• Mikrobiologie
• Biochemie
• Englisch
• Immunologie
• Chinesische Kultur
• Französisch
• Biowissenschaften
• Datenanalyse
• Facs
• Flowcytometry
• Tiermodelle
• Zellkulturen
• Projektmanagement
• Biotechnologie